Search Tag: Masimo
Masimo-announces-bridgetm
2020 29 Jun
Drug-free Neurostimulation Device Reduces the Symptoms of Opioid Withdrawal Masimo today announced Bridge™, an opioid withdrawal solution that uses neuromodulation to aid in the reduction of symptoms associated with opioid withdrawal. Bridge, which has been granted an FDA De Novo classification, is the first evidence-based, drug-free, non-surgical...Read more
Masimo-announces-fda-clearance-of-centroidtm
2020 25 Jun
Wearable, Wireless Patient Orientation, Activity, and Respiration Sensor Helps Clinicians Monitor Patient Position and Respiration Rate Masimo announced today that Centroid™, a wearable, wireless patient orientation, activity, and respiration rate sensor, has received FDA clearance. Centroid helps clinicians monitor patient position to avoid...Read more
Masimo-announces-masimo-safetynet-opentm
2020 19 Jun
Suite of Integrated Turnkey Tools Helps Businesses, Governments, and Schools Reopen and Stay Open Responsibly During COVID-19 IRVINE, Calif.--( BUSINESS WIRE )-- Masimo (NASDAQ: MASI) today announced Masimo SafetyNet-Open™, designed to help businesses, governments, and schools more responsibly manage employee and student health and safety...Read more
New-agreement-brings-masimo-nomoline-r-capnography-o3-r-regional-oximetry-to-select-philips-monitors
2020 27 May
Masimo and Royal Philips , both global leaders in patient monitoring, announced today that they have reinforced their partnership, whereby Philips will integrate additional Masimo measurement technologies into select IntelliVue® MX-series multi-parameter monitors, to help clinicians assess cerebral oximetry and ventilation status. Core Masimo...Read more
Patient-safety-movement-foundation-awarded-5-million
2020 14 Apr
Masimo Foundation for Ethics, Innovation, and Competition in Healthcare Pledges Five Years of Support The Patient Safety Movement Foundation (PSMF), a global organization dedicated to achieving zero preventable hospital deaths worldwide, is pleased to announce the acceptance of a five-year, $5 million grant from the Masimo Foundation for Ethics,...Read more
Masimo-drager-expand-licensing-agreement-to-add-masimo-brain-monitoring-capnography-technologies
2019 19 Dec
Masimo and Dräger announced today that they have expanded their partnership, whereby Dräger will integrate additional Masimo measurement technologies into Dräger’s family of multi-parameter patient monitors, to help clinicians assess brain function, oxygenation, and ventilation status. This press release features multimedia. View the full release...Read more
Multicenter-study-evaluates-trend-accuracy-of-three-hb-monitoring-methods-including-masimo-sphb
2019 09 Dec
Masimo announced today that in a multicenter study recently published in the Journal of Clinical Monitoring and Computing, researchers at three institutions – Loma Linda University in California (LLU), the University of California at Irvine (UCI), and Mayo Clinic in Jacksonville, Florida (MCF) – evaluated the trend accuracy of three hemoglobin (Hb)...Read more
Masimo-ce-marking-of-radius-capnography-for-the-root-r-patient-monitoring-and-connectivity-platform
2019 31 Oct
Radius Capnography with Bluetooth® Connectivity Seamlessly Integrates Tetherless Mainstream Capnography on Root Masimo announced today that Radius Capnography™, a portable real-time capnograph with wireless Bluetooth® connectivity, has received CE marking. Radius Capnography connects with the Root® Patient Monitoring and Connectivity Platform...Read more
Masimo-announces-development-of-delta-chb-hhb-and-o2hb-indices-for-o3-r
2019 09 Sep
Masimo announced today three additional indices (delta cHb, delta HHb, and delta O2Hb) for O3® Regional Oximetry . These indices provide clinicians with additional visibility into changes in the underlying oxyhemoglobin and deoxyhemoglobin components used to calculate cerebral oxygen saturation, rSO2. With these additions, clinicians will now be...Read more
Masimo-announces-pathway-for-the-root-r-patient-monitoring-and-connectivity-platform
2019 04 Sep
Masimo today announced Pathway™, a feature for the Root® Patient Monitoring and Connectivity Platform . Pathway provides clinicians with a way to visualize a hospital’s recommended resuscitation protocol for a newborn’s oxygen saturation (SpO2) while continuously monitoring SpO2 and pulse rate (PR) during the first ten minutes after birth. Use of...Read more
Study-the-utility-of-masimo-ori-to-reduce-hyperoxia-in-critically-ill-patients
2019 26 Aug
Masimo announced today that in a randomized controlled study involving 150 ICU patients recently published as a letter in Intensive Care Medicine, researchers investigated whether monitoring with Masimo ORi™ (Oxygen Reserve Index) could reduce the time critically ill patients spend with moderate hyperoxia, compared to monitoring with oxygen saturation...Read more
Masimo-and-mindray-announce-expanded-partnership
2019 13 May
Mindray to Offer Masimo SET ® Pulse Oximetry in its Patient Monitoring Devices in Additional Countries Beyond the United States. Masimo and Shenzhen Mindray Bio-Medical Electronics Co., Ltd. announced today that they have entered into a purchase and license agreement, under which Mindray will offer Masimo SET® Measure-through Motion...Read more
Masimo-announces-fda-clearance-of-the-rainbow-acoustic-monitoring-r-ras-45-sensor
2018 10 Sep
Masimo announced today FDA clearance of RAS-45, an acoustic respiration sensor for rainbow Acoustic Monitoring® (RAM®), for infant and neonatal patients. RAM could previously be used to monitor adult and pediatric patients greater than 10 kg using RAS-125c and RAS-45 sensors. With clearance of the RAS-45 sensor for infant and neonatal patients, acoustic...Read more
New-study-investigates-the-utility-of-masimo-pvi-r-in-patients-undergoing-colorectal-surgery
2018 18 Jul
Masimo Radical-7® with PVi®, SpHb®, and RD rainbow SET™ Masimo (NASDAQ: MASI) has announced the findings of a recently published study in which researchers at Kocaeli University in Turkey compared the performance of conventional fluid management (CFM) to goal-directed fluid management (GDFM) using Masimo PVi® (pleth variability index, measured...Read more
Masimo-announces-vital-signs-check-application-for-the-root-r-patient-monitoring-platform
2018 09 Jul
Masimo has announced the worldwide release of the Vital Signs Check Application, an integrated patient data collection and workflow application for the Masimo Root® patient monitoring and connectivity platform. Vital Signs Check, available for new and existing Root customers through a software upgrade, augments Root’s versatility by helping to automate...Read more
Masimo-and-positiveid-announce-the-u-s-release-of-tir-1
2018 20 Jun
Masimo and Thermomedics, a PositiveID company, has announced the debut and U.S. market release of TIR-1™, a non-contact Bluetooth®-enabled thermometer that integrates seamlessly with the Masimo Root® patient monitoring and connectivity platform. TIR-1 is an easy-to-use, clinical-grade infrared thermometer that provides forehead temperature measurements...Read more
Study-investigates-the-utility-of-continuous-noninvasive-hemoglobin-measurement-with-masimo-sphb-r
2018 05 Jun
Masimo has announced the findings of an abstract presented at Euroanaesthesia 2018 in which researchers compared Masimo noninvasive and continuous hemoglobin (SpHb®) to intermittent and invasive lab hemoglobin (LabHb) in reflecting iatrogenic hemodilution during incremental fluid administration of patients undergoing major surgery. 1...Read more
Masimo-set-r-pulse-oximetry-helps-form-basis-of-utah-senate-resolution
2018 08 May
The Utah State Legislature and Governor Gary Herbert have recently signed into law the Concurrent Resolution on Deaths From Opioid-Induced Postoperative Respiratory Depression (SCR4). The resolution urges hospitals, clinicians, and researchers to examine and identify possible links between opioids and respiratory depression following surgery and encourages...Read more
Masimo-o3-r-regional-oximetry-and-sedline-r-brain-function-monitoring-power-two-investigations
2018 03 May
Masimo has announced the use of Masimo technologies – O3® regional oximetry and SedLine® brain function monitoring – in two abstracts presented at the 2018 Annual Meeting of the International Anesthesia Research Society(IARS). Both studies investigated links between postoperative delirium and particular biomarkers. In the first study 1 , Dr. Aymen...Read more
Study-investigates-the-utility-of-masimo-sphb-r-in-post-operative-red-rbc-transfusion-best-practices
2018 23 Apr
Masimo announced today the findings of an abstract presented at the 2018 Annual Meeting of the Network for the Advancement of Patient Blood Management, Haemostatis and Thrombosis (NATA), in which researchers investigated the utility of Masimo noninvasive and continuous hemoglobin (SpHb®) in supporting and enhancing red blood cell (RBC) transfusion...Read more
Masimo-announces-uniview-1
2018 02 Apr
Masimo announced today the release of UniView™, an integrated display of real-time data and alarms from multiple Masimo and third-party devices, designed to reduce clinician cognitive overload and improve patient safety. UniView promotes data sharing and team coordination among multiple clinicians. In operating rooms (ORs), in intensive care units...Read more
New-study-investigates-the-performance-of-masimo-sphb-r
2018 12 Mar
Masimo announced today the findings of a recently published study in which researchers at Cairo University in Egypt evaluated the accuracy and trending of Masimo noninvasive and continuous hemoglobin (SpHb®), referenced to an invasive laboratory hemoglobin (Lab-Hb) measurement, during acute bleeding and after fluid resuscitation. In the study,...Read more
Masimo-announces-replica
2018 06 Mar
Today at the 2018 HIMSS Annual Conference, Masimo announced the release of Replica™, an application for smart phones and tablets that works in conjunction with Masimo Patient SafetyNet™*, a supplemental remote monitoring and clinician notification system. Replica allows clinicians to view continuous monitoring data for multiple patients, as well...Read more
Leading-nephrology-care-center-in-india-adopts-masimo-technologies-across-continuum-of-care
2018 28 Feb
Masimo announced today that NU Hospitals, a leading nephrology care center in India, has standardized on Masimo technologies across the continuum of care. NU Hospitals have entered into a strategic partnership with Masimo to adopt technologies in their operating rooms (ORs), intensive care units (ICUs), dialysis beds, and general wards at both of their...Read more
New-study-evaluates-the-performance-of-masimo-sphb-r-in-monitoring-pediatric-trauma-patients
2018 22 Feb
Masimo announced today the findings of a recently published study in which researchers at Michigan State University evaluated the performance of noninvasive hemodynamic monitoring (NIHM) using Masimo noninvasive and continuous hemoglobin (SpHb®), as compared to invasive laboratory hemoglobin (LabHb) monitoring, in clinically stable pediatric trauma...Read more
Medical-device-companies-pledge-to-share-data-that-can-save-the-lives-of-patients
2018 21 Feb
The medical technology field spans a multi-billion dollar market, and corporate competitiveness has long been viewed as the key to staying ahead. But Joe Kiani, Chairman, and CEO of the medical technology company, Masimo, is bringing fierce competitors together for the sake of patient safety. As a strong advocate for patient safety, Kiani founded...Read more
New-study-evaluates-the-performance-of-masimo-pvi-r-as-a-predictor-of-fluid-responsiveness
2018 12 Feb
Masimo announced today the findings of a recently published study in which researchers at Bülent Ecevit University in Zonguldak, Turkey compared two noninvasive methods of predicting fluid responsiveness in mechanically ventilated patients in the intensive care unit (ICU): Masimo PVi® (pleth variability index, measured noninvasively and continuously...Read more
Artemis-hospital-becomes-first-in-india-to-adopt-masimo-patient-safetynet
2017 05 Dec
Masimo announced today that Artemis Hospital, one of the leading multi-specialty hospitals in the Delhi-NCR region of India, is adopting Masimo Patient SafetyNet™*, a supplemental remote monitoring and clinician notification system, across all hospital care areas. Patient SafetyNet, in conjunction with SET® pulse oximetry and rainbow® pulse CO-oximetry,...Read more
Masimo-announces-u-s-release-of-trace-data-visualization-and-reporting-tool
2017 07 Oct
Masimo Trace™ Data Visualization and Reporting Tool Masimo has announced that the U.S. release of Trace™, patient data visualization and reporting software designed for Masimo Root® and Radical-7® monitors. Trace is the first data visualization and reporting software compatible with the full capabilities of the Masimo Root Patient...Read more
Masimo-announces-full-market-release-of-rainbow-acoustic-monitoring-sensor-ras-45
2017 02 Oct
Masimo rainbow Acoustic Monitoring® RAS-45 Acoustic Respiration Sensor Masimo has announced the full market release of RAS-45, an adhesive adult and pediatric acoustic respiration sensor for rainbow Acoustic Monitoring® (RAM™). RAS-45 offers the same performance as the currently available RAS-125c sensor but in a smaller size, with more flexible...Read more